Jeffrey Bishop, Interim Vietnam Country Manager, Takeda (L), and Assoc. Prof. Dr. Tran Thi Thanh Huong, Director of the Bright Future Fund (R) at the signing ceremony for the partnership agreement between two organizations for the initiative to support blood cancer patients in 2023 Hanoi, (VNA) - Hematopoietic system cancer (a.k.a. blood cancer) is one of the most dangerous types of cancer with complicated developments. The patients can face a high risk of serious complications leading to death if the disease is not detected early and treated promptly. A survey conducted in 2022 with blood cancer patients at Vietnam National Cancer Hospital, National Institute of Hematology and Blood Transfusion, and Blood Transfusion and Hematology Hospital in Ho Chi Minh City revealed that 48% of surveyed patients are in the age group of 21-40 years old (accounting for the highest patient rate), 10% of patients are under 20 years old and 16% of patients are over 40 years old. Many … [Read more...] about Takeda continues to empower patients with hematopoietic system cancer with Bright Future Fund